AORT.NYSEArtivion, INC

Form 4: Artivion Director James Bullock Acquires Shares Through Restricted Stock Award

Sentiment:

SEC Form 4


Director James Bullock acquired 6,289 shares of Artivion, Inc. common stock through a restricted stock award that vests on May 30, 2025.

Summary

  • On May 30, 2024, James Bullock, a director of Artivion, Inc., acquired 6,289 shares of common stock.
  • The acquisition was a result of a restricted stock award (RSA) grant.
  • The RSA vests on May 30, 2025, according to the terms of the Equity and Cash Incentive Plan.
  • Following the transaction, Bullock directly owns 62,322 shares of Artivion, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director, which doesn't inherently indicate positive or negative sentiment but suggests alignment with the company's long-term performance.

Positives

  • The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency into the ownership changes of company insiders.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder confidence, as it signals that a director is increasing their stake in the company.

Key Dates

DateDescription
05/30/2024Date of transaction: James Bullock acquired 6,289 shares of Artivion, Inc. common stock.
05/30/2025Vesting date of the restricted stock award.
06/03/2024Date of signature for the SEC Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.